Bausch + Lomb has abandoned its next great hope in glaucoma after the eye drops flunked a phase 2 study. The eye health company had been evaluating the alpha-2B agonist, dubbed BL1107, in a mid-stage ...

Supplementation with vitamin B3 is associated with a 66% lower risk of developing glaucoma in people with high eye pressure, a real-world study shows.

When most people think about their eyesight, they focus (literally) on what is directly in front of them. To see something off to one side, they turn their head and/or eyes. If, instead of turning to ...

Eyecare company Bausch + Lomb has had a hole blown in its pharma pipeline, after disappointing trial results forced it to ...

How equitably are glaucoma medications being dispensed across a universal health care system, and how have prescribing ...

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

One of the most common things I hear from my Chinese-speaking patients when discussing their glaucoma care is simple and ...

Equipment needs to be purchased in Schedule 1 to get you up and running, but it soon becomes obsolete and needs to be upgraded. On top of that, you might have bought some items that were useful in the ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced topline results from its Phase 2 study evaluating ...

Bausch + Lomb announced topline results from its phase 2 study of BL1107 in patients with glaucoma. According to the company, ...

What is causing eye doctors to move away from the traditional "wait and see" approach for glaucoma and cataracts? HelloNation has published an article that answers this question, drawing on insights ...

If you live with a senior cat, noticing signs of vision loss in your friend can be heartbreaking, raising concerns about ...